Pricing Log in Create free account

Aytu BioPharma, Inc. (AYTU) vs Incannex Healthcare Inc. (IXHL)

Aytu BioPharma, Inc. and Incannex Healthcare Inc. are both Drug Manufacturers Specialty & Generic companies. Incannex Healthcare Inc. is the larger, with a market value of $36.1M against $21.8M — 1.7× the size. Incannex Healthcare Inc. has the higher net margin (0.00% vs −24.8%) and the higher return on invested capital (0.00% vs −20.0%). Across the 17 metrics below, Incannex Healthcare Inc. leads on 10 and Aytu BioPharma, Inc. on 7.

Valuation

Metric AYTU IXHL Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S 0.44 21.06 2.11
P/B 0.71 0.49 1.78
Price to free cash flow 7.77 n/m 16.14
EV/EBITDA n/m 1.36 12.58
EV/Sales 0.28 (19.90) 2.73
Earnings yield (67.16%) (60.71%) (4.38%)
Free cash flow yield 12.87% (39.17%) 0.00%

Profitability

Metric AYTU IXHL Drug Manufacturers Specialty & Generic median
Gross margin 63.95% (0.10%) 53.94%
Operating margin (14.44%) 0.00% 0.00%
Net margin (24.76%) 0.00% 0.00%
Free cash flow margin 5.62% 0.00% 0.00%
Return on equity (52.55%) (47.80%) (0.40%)
Return on assets (12.44%) (41.32%) (3.32%)
Return on invested capital (19.99%) 0.00% 0.00%

Growth

Metric AYTU IXHL Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (13.27%) — 10.01%
EPS growth (last fiscal year) 46.30% 95.91% 49.06%
Revenue growth, 5-year CAGR (2.59%) (29.64%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AYTU IXHL Drug Manufacturers Specialty & Generic median
Debt to equity 0.48 0.00 0.05
Current ratio 1.13 48.81 2.31
Net debt to EBITDA 2.17 2.97 0.97

Dividend

Metric AYTU IXHL Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric AYTU IXHL Drug Manufacturers Specialty & Generic median
Market cap 21.84m 36.12m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack